ARTICLE | Clinical News
Prostate cancer vaccine: Phase I/II data
August 10, 2009 7:00 AM UTC
Medical Marketing International Group plc (LSE:MMG), Cambridge, U.K. Product: Prostate cancer vaccine Business: Cancer Molecular target: Prostate-specific membrane antigen ( PSMA) Description: DNA va...